Literature DB >> 20002089

Potentially inappropriate prescribing in an Irish elderly population in primary care.

Cristín Ryan1, Denis O'Mahony, Julia Kennedy, Peter Weedle, Stephen Byrne.   

Abstract

WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: * Potentially inappropriate prescribing in older people is a well-documented problem and has been associated with adverse drug reactions and hospitalization. * Beers' criteria, Screening Tool of Older Persons' potentially inappropriate Prescriptions (STOPP) and Screening Tool to Alert doctors to Right Treatment (START) are screening tools that have been formulated to help physicians and pharmacists identify potentially inappropriate prescribing and potential prescribing omissions. * The prevalence of potentially inappropriate prescribing and prescribing omissions in the elderly population presenting to hospital with acute illness is high according to STOPP and START criteria. WHAT THIS STUDY ADDS: * Potential errors of prescribing and of omission of medicines are prevalent among medically stable older people in primary care. * Screening tools should be incorporated into the everyday practice of primary care doctors and community pharmacists as a means of preventing potential errors of prescribing commission and prescribing omission in older people. AIMS: Screening tools have been formulated to identify potentially inappropriate prescribing (IP) in older people. Beers' criteria are the most widely used but have disadvantages when used in Europe. New IP screening tools called Screening Tool of Older Person's Prescriptions (STOPP) and Screening Tool to Alert doctors to Right Treatment (START) have been developed to identify potential IP and potential prescribing omissions (PPOs). The aim was to measure the prevalence rates of potential IP and PPOs in primary care using Beers' criteria, STOPP and START.
METHODS: Case records of 1329 patients >or=65 years old from three general practices in one region of southern Ireland were studied. The mean age +/- SD of the patients was 74.9 +/- 6.4 years, 60.9% were female. Patients' current diagnoses and prescription medicines were reviewed and the Beers' criteria, STOPP and START tools applied.
RESULTS: The total number of medicines prescribed was 6684; median number of medicines per patient was five (range 1-19). Overall, Beers' criteria identified 286 potentially inappropriate prescriptions in 18.3% (243) of patients, whilst the corresponding IP rate identified by STOPP was 21.4% (284), in respect of 346 potentially inappropriate prescriptions. A total of 333 PPOs were identified in 22.7% (302) of patients using the START tool.
CONCLUSION: Potentially inappropriate drug prescribing and errors of drug omission are highly prevalent among older people living in the community. Prevention strategies should involve primary care doctors and community pharmacists.

Entities:  

Mesh:

Year:  2009        PMID: 20002089      PMCID: PMC2810806          DOI: 10.1111/j.1365-2125.2009.03531.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  39 in total

1.  Acove quality indicators.

Authors:  P G Shekelle; C H MacLean; S C Morton; N S Wenger
Journal:  Ann Intern Med       Date:  2001-10-16       Impact factor: 25.391

2.  Development and validation of an improving prescribing in the elderly tool.

Authors:  C T Naugler; C Brymer; P Stolee; Z A Arcese
Journal:  Can J Clin Pharmacol       Date:  2000

3.  Preventable drug-related hospital admissions.

Authors:  Almut G Winterstein; Brian C Sauer; Charles D Hepler; Charles Poole
Journal:  Ann Pharmacother       Date:  2002 Jul-Aug       Impact factor: 3.154

Review 4.  The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence.

Authors:  Gordon G Liu; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

5.  Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA).

Authors:  Graziano Onder; Claudio Pedone; Francesco Landi; Matteo Cesari; Cecilia Della Vedova; Roberto Bernabei; Giovanni Gambassi
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

6.  Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey.

Authors:  C Zhan; J Sangl; A S Bierman; M R Miller; B Friedman; S W Wickizer; G S Meyer
Journal:  JAMA       Date:  2001-12-12       Impact factor: 56.272

7.  Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice.

Authors:  A G Zermansky; D R Petty; D K Raynor; N Freemantle; A Vail; C J Lowe
Journal:  BMJ       Date:  2001-12-08

8.  Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care.

Authors:  J Krska; J A Cromarty; F Arris; D Jamieson; D Hansford; P R Duffus; G Downie; D G Seymour
Journal:  Age Ageing       Date:  2001-05       Impact factor: 10.668

Review 9.  Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis.

Authors:  Jannette M Parr; David J Kavanagh; Lareina Cahill; Geoffrey Mitchell; Ross McD Young
Journal:  Addiction       Date:  2008-10-31       Impact factor: 6.526

10.  Inappropriate drug prescribing in home-dwelling, elderly patients: a population-based survey.

Authors:  Kaisu H Pitkala; Timo E Strandberg; Reijo S Tilvis
Journal:  Arch Intern Med       Date:  2002 Aug 12-26
View more
  102 in total

Review 1.  Inappropriate prescribing: criteria, detection and prevention.

Authors:  Marie N O'Connor; Paul Gallagher; Denis O'Mahony
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

Review 2.  Comparison of published explicit criteria for potentially inappropriate medications in older adults.

Authors:  Chirn-Bin Chang; Ding-Cheng Chan
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

Review 3.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

4.  Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States.

Authors:  Joshua D Brown; Lisa C Hutchison; Chenghui Li; Jacob T Painter; Bradley C Martin
Journal:  J Am Geriatr Soc       Date:  2016-01       Impact factor: 5.562

5.  Potentially inappropriate medications in geriatric outpatients with polypharmacy: application of six sets of published explicit criteria.

Authors:  Chirn-Bin Chang; Jen-Hau Chen; Chiung-Jung Wen; Hsu-Ko Kuo; I-Shu Lu; Lee-Shu Chiu; Shwu-Chong Wu; Ding-Cheng Derrick Chan
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

6.  Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?

Authors:  Encarnación Blanco-Reina; Gabriel Ariza-Zafra; Ricardo Ocaña-Riola; Matilde León-Ortíz; Inmaculada Bellido-Estévez
Journal:  Eur J Clin Pharmacol       Date:  2014-11-09       Impact factor: 2.953

Review 7.  Underprescription of medications in older adults: causes, consequences and solutions-a narrative review.

Authors:  F Lombardi; L Paoletti; B Carrieri; G Dell'Aquila; M Fedecostante; M Di Muzio; A Corsonello; F Lattanzio; A Cherubini
Journal:  Eur Geriatr Med       Date:  2021-03-11       Impact factor: 1.710

8.  A prevalence study of potentially inappropriate prescribing in Irish long-term care residents.

Authors:  David P O'Sullivan; Denis O'Mahony; Carole Parsons; Carmel Hughes; Kevin Murphy; Susan Patterson; Stephen Byrne
Journal:  Drugs Aging       Date:  2013-01       Impact factor: 3.923

9.  A comparison of the application of STOPP/START to patients' drug lists with and without clinical information.

Authors:  Cristín Ryan; Denis O'Mahony; Dónal Óg O'Donovan; Emer O'Grady; Peter Weedle; Julia Kennedy; Stephen Byrne
Journal:  Int J Clin Pharm       Date:  2012-12-09

10.  Pharmacological management of co-morbid conditions at the end of life: is less more?

Authors:  S McLean; B Sheehy-Skeffington; N O'Leary; A O'Gorman
Journal:  Ir J Med Sci       Date:  2012-07-29       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.